Jonsson Comprehensive Cancer Center
Clinical trials sponsored by Jonsson Comprehensive Cancer Center, explained in plain language.
-
New drug combo aims to shrink tumors before lung cancer surgery
Disease control Not yet recruitingThis study is testing a new drug, zipalertinib, given with standard chemotherapy before surgery for patients with a specific type of operable non-small cell lung cancer. The goal is to see if this combination can shrink or kill more of the tumor before it is surgically removed. R…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for rare blood cancers? immune therapy trial seeks to tame disease
Disease control Not yet recruitingThis study is testing a long-acting immune therapy drug called ropeginterferon alfa-2b for adults with rare, overlapping blood cancers like chronic myelomonocytic leukemia (CMML). The main goals are to find a safe and effective dose and to see if the drug can control the disease …
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug duo aims to wipe out lingering cancer cells
Disease control Not yet recruitingThis study is testing whether two oral drugs, imlunestrant and abemaciclib, can clear tiny amounts of leftover cancer DNA from the blood in people with early-stage, hormone-sensitive breast cancer. The goal is to see if this treatment can prevent the cancer from coming back. Abou…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for Tough-to-Treat lung cancer: trial tests 'Smart Bomb' drug combo
Disease control Not yet recruitingThis study is testing whether combining two targeted drugs can help control advanced non-small cell lung cancer that has started growing again after standard treatment. The trial will enroll about 60 adults whose cancer has a specific genetic profile. One drug is a 'smart bomb' t…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New radiation technique aims to zap prostate cancer while sparing Men's quality of life
Disease control Not yet recruitingThis study is testing a more precise form of radiation therapy for men with early-stage prostate cancer. The goal is to see if targeting radiation directly at the main tumor can effectively control the cancer while causing fewer long-term side effects, like problems with urinatio…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New brain scan could help surgeons cut out more cancer
Disease control Not yet recruitingThis study is testing whether using a special type of MRI scan during surgery helps doctors remove more of a deadly brain tumor called glioblastoma. The new scan aims to reveal hidden cancer cells that standard scans miss. Researchers will compare this new surgical approach to th…
Phase: PHASE3 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
Spring-Powered healing: portable device aims to speed recovery from skin cancer surgery
Symptom relief Not yet recruitingThis study is testing whether a portable, spring-powered wound vacuum device helps leg wounds heal faster after skin cancer removal surgery. Researchers will compare the portable device against standard wound dressings in 60 patients. The goal is to see if this easier-to-use, at-…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC
-
Home workouts aim to rebuild lives after stomach cancer
Symptom relief Not yet recruitingThis study is testing a personalized, home-based exercise program for people who have completed treatment for stomach or esophageal cancer. The goal is to see if supervised workouts delivered remotely can help survivors regain physical strength, reduce fatigue, and improve their …
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 18, 2026 14:41 UTC